Expertise in
21
conditions

Dr. Stephen M. Lindsey

Rheumatology
Children's Hospital New Orleans
200 Henry Clay Ave, 
New Orleans, LA 
Accepting New Patients
Referral may be required
Before you request
Expertise in
21
conditions
Children's Hospital New Orleans
200 Henry Clay Ave, 
New Orleans, LA 

Overview

Stephen Lindsey is a Rheumatologist practicing medicine in New Orleans, Louisiana.

Dr. Lindsey is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Lupus Nephritis, Scleroderma, and Systemic Sclerosis (SSc).

He is actively involved in clinical research, co-authoring 7 peer reviewed articles and participating in 5 clinical trials. Dr. Lindsey is currently accepting new patients.

Specialties

Rheumatology

Licenses

Internal Medicine in LA

Hospital Affiliations

University Medical Center New Orleans

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Magnolia Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 4 Less Insurance Carriers -

Locations

Children's Hospital New Orleans
200 Henry Clay Ave, New Orleans, LA 70118
Other Locations
East Baton Rouge Medical Center LLC
9001 Summa Ave, Baton Rouge, LA 70809

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: June 24, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
Enrollment Status: Completed
Publish Date: March 20, 2026
Intervention Type: Other, Biological
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
Enrollment Status: Completed
Publish Date: November 23, 2021
Intervention Type: Drug, Biological
Study Drug: Zostavax Herpes Zoster Vaccine
Study Phase: Phase 2
View 4 Less Clinical Trials

7 Total Publications

A Phase 3 Trial of Brepocitinib in Dermatomyositis.
A Phase 3 Trial of Brepocitinib in Dermatomyositis.
Journal: The New England journal of medicine
Published: March 30, 2026
Similar Doctors
Expertise in
10
conditions
Expertise in
10
conditions
Referral may be required
Before you request

University Medical Center New Orleans

1542 Tulane Ave, 
New Orleans, LA 
 (3.9 miles away)
504-702-5700
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Lesley Saketkoo is a Rheumatologist practicing medicine in New Orleans, LA. Dr. Saketkoo is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Sarcoidosis, Scleroderma, Systemic Sclerosis (SSc), and Myositis. Dr. Saketkoo is currently accepting new patients.

Expertise in
29
conditions
Expertise in
29
conditions
Referral required
Before you request

Ochsner Medical Center - New Orleans

1514 Jefferson Hwy, 
New Orleans, LA 
 (3.2 miles away)
504-842-3920
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Robert Quinet is a Rheumatologist practicing medicine in New Orleans, Louisiana. Dr. Quinet is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Scleroderma, Systemic Sclerosis (SSc), and Scleroma. Dr. Quinet is board certified in American Board Of Internal Medicine - Rheumatology and American Board Of Internal Medicine - Internal Medicine. Dr. Quinet is currently accepting new patients.

Expertise in
40
conditions
Dr. Louis D. Perdue
Rheumatology
Expertise in
40
conditions
Dr. Louis D. Perdue
Rheumatology
Referral may be required

Joseph J Biundo JR MD Apmc

4315 Houma Blvd Ste 303, 
Metairie, LA 
 (7.7 miles away)
504-889-5242
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Louis Perdue is a Rheumatologist practicing medicine in Metairie, Louisiana. Dr. Perdue is highly rated in 40 conditions, according to our data. His clinical expertise encompasses Felty Syndrome, Fibromyalgia, Gout, and Rheumatoid Arthritis (RA). Dr. Perdue is currently accepting new patients.

Frequently Asked Questions about Dr. Stephen M. Lindsey

How do I make an appointment with Dr. Stephen M. Lindsey?

You can book an appointment with Dr. Stephen M. Lindsey by calling their office at 225-761-5200. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Stephen M. Lindsey a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Stephen M. Lindsey is classified as an Distinguished expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Stephen M. Lindsey specialize in?

While Dr. Stephen M. Lindsey is a Rheumatology, they have specific expertise in Rheumatoid Arthritis (RA), Lupus Nephritis, and Scleroderma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Stephen M. Lindsey participate in research or clinical trials?

Yes. Dr. Stephen M. Lindsey has published 7 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Dr. Stephen M. Lindsey's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Stephen M. Lindsey accept my insurance?

Dr. Stephen M. Lindsey accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 225-761-5200 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lindsey's expertise for a condition
ConditionClose
    View All 15 Advanced Conditions
    View All 36 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile